Delivery Order SPE2DR25D3005-SPE2DR26FP9BL
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Aponvie 32 mg/4.4 mL vials with a ceiling value of $2,470.69 under a firm fixed price contract. This delivery order represents a non-set-aside, competitively awarded procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $6,903.91 delivery order to AmerisourceBergen Drug Corp for Aponvie 32 mg/4.4 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price contract represents a non-set-aside award issued under open competition and is characterized as a child contract, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $13,881.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Aponvie 32 mg/4.4 ml vials. The contract, which represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded with no set-aside designation. Performance will be conducted at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,294.39 to AmerisourceBergen Drug Corp for the supply of Aponvie 32 mg/4.4 mL vials on a firm fixed-price basis. The award was made on January 15, 2026, with an ultimate completion date of January 16, 2026, and represents a non-set-aside competitive procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.20 firm fixed-price delivery order is for the supply of APONVIE 32 MG/4.4 ML VIAL 4.4ML, a pharmaceutical product. The contract has an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $3,471.02 to AmerisourceBergen Drug Corp for the supply of Aponvie 32 mg/4.4 mL vials. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of APONVIE 32 MG/4.4 ML VIAL 4.4ML, a pharmaceutical product, to be completed by February 28, 2024. The potential value of this delivery order is $1,138.38. No set-aside designations were used. Amerisourcebergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a $7,253.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BOMYNTRA 120 mg/1.7 mL vials on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-competitive delivery order represents a small-value pharmaceutical procurement executed without set-aside designation. The contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,911.94 to AmerisourceBergen Drug Corp for 100 tablets of Onfivamide 10 mg, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop...
- This federal contract award, valued at $1,897.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of APONVIE 32 MG/4.4 ML VIAL 4.4ML pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. Under this single-award IDC,...